185 related articles for article (PubMed ID: 37208786)
41. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
Bonuccelli G; Sotgia F; Capozza F; Gazzerro E; Minetti C; Lisanti MP
Cell Cycle; 2007 May; 6(10):1242-8. PubMed ID: 17495527
[TBL] [Abstract][Full Text] [Related]
42. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
43. Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice.
Williams JH; Schray RC; Sirsi SR; Lutz GJ
BMC Biotechnol; 2008 Apr; 8():35. PubMed ID: 18384691
[TBL] [Abstract][Full Text] [Related]
44. Sarcoplasmic reticulum calcium handling in unbranched, immediately post-necrotic fast-twitch mdx fibres is similar to wild-type littermates.
Chan S; Kueh SLL; Morley JW; Head SI
Exp Physiol; 2022 Jun; 107(6):601-614. PubMed ID: 35471703
[TBL] [Abstract][Full Text] [Related]
45. Bone tissue and muscle dystrophin deficiency in mdx mice.
Nakagaki WR; Camilli JA
Joint Bone Spine; 2012 Mar; 79(2):129-33. PubMed ID: 22079415
[TBL] [Abstract][Full Text] [Related]
46. The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres.
Woods CE; Novo D; DiFranco M; Vergara JL
J Physiol; 2004 May; 557(Pt 1):59-75. PubMed ID: 15004213
[TBL] [Abstract][Full Text] [Related]
47. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
[TBL] [Abstract][Full Text] [Related]
48. A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the
Wright CR; Allsopp GL; Addinsall AB; McRae NL; Andrikopoulos S; Stupka N
Mediators Inflamm; 2017; 2017():7043429. PubMed ID: 28592916
[TBL] [Abstract][Full Text] [Related]
49. Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers.
Shkryl VM; Martins AS; Ullrich ND; Nowycky MC; Niggli E; Shirokova N
Pflugers Arch; 2009 Sep; 458(5):915-28. PubMed ID: 19387681
[TBL] [Abstract][Full Text] [Related]
50. Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice.
Sirsi SR; Schray RC; Guan X; Lykens NM; Williams JH; Erney ML; Lutz GJ
Hum Gene Ther; 2008 Aug; 19(8):795-806. PubMed ID: 18647087
[TBL] [Abstract][Full Text] [Related]
51. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
[TBL] [Abstract][Full Text] [Related]
52. Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.
Kim MH; Kay DI; Rudra RT; Chen BM; Hsu N; Izumiya Y; Martinez L; Spencer MJ; Walsh K; Grinnell AD; Crosbie RH
Hum Mol Genet; 2011 Apr; 20(7):1324-38. PubMed ID: 21245083
[TBL] [Abstract][Full Text] [Related]
53. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
Kumar A; Bhatnagar S; Kumar A
Am J Pathol; 2010 Jul; 177(1):248-60. PubMed ID: 20472898
[TBL] [Abstract][Full Text] [Related]
55. Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.
Timpani CA; Trewin AJ; Stojanovska V; Robinson A; Goodman CA; Nurgali K; Betik AC; Stepto N; Hayes A; McConell GK; Rybalka E
Neurotherapeutics; 2017 Apr; 14(2):429-446. PubMed ID: 27921261
[TBL] [Abstract][Full Text] [Related]
56. Contractile properties of myocardium are altered in dystrophin-deficient mdx mice.
Sapp JL; Bobet J; Howlett SE
J Neurol Sci; 1996 Oct; 142(1-2):17-24. PubMed ID: 8902714
[TBL] [Abstract][Full Text] [Related]
57. Dissociation of SH3 and cysteine-rich domain 3 and junctophilin 1 from dihydropyridine receptor in dystrophin-deficient muscles.
Ashida Y; Himori K; Tokuda N; Naito A; Yamauchi N; Takenaka-Ninagawa N; Aoki Y; Sakurai H; Yamada T
Am J Physiol Cell Physiol; 2022 Sep; 323(3):C885-C895. PubMed ID: 35912995
[TBL] [Abstract][Full Text] [Related]
58. Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Kayali R; Ku JM; Khitrov G; Jung ME; Prikhodko O; Bertoni C
Hum Mol Genet; 2012 Sep; 21(18):4007-20. PubMed ID: 22692682
[TBL] [Abstract][Full Text] [Related]
59. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
60. Accumulation of Dystrophin-Positive Muscle Fibers and Improvement of Neuromuscular Junctions in mdx Mouse Muscles after Bone Marrow Transplantation under Different Conditions.
Sokolova AV; Domnina AP; Mikhailov VM
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
